Life-threatening interstitial lung disease associated with trastuzumab: Case report

Breast Cancer Research and Treatment

Volumn 113, Issue 3, 2009, Pages 609-612

  Pepels, M J ^a   Boomars, K A ^a   Van Kimmenade, R ^a   Hupperets, P S ^a  

^a MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Breast cancer; Dyspnoea; Eosinophils; Infiltrates; Trastuzumab

Indexed keywords

CYCLOPHOSPHAMIDE; DEXAMETHASONE; DOCETAXEL; DOXORUBICIN; EPIDERMAL GROWTH FACTOR RECEPTOR 2; FLUOROURACIL; OXYCODONE; PREDNISOLONE; TRASTUZUMAB;

ADULT; ARTICLE; BREAST CANCER; CANCER REGRESSION; CASE REPORT; DYSPNEA; EOSINOPHIL; FEMALE; HISTOPATHOLOGY; HUMAN; INTERSTITIAL LUNG DISEASE; LUNG INFILTRATE; LUNG LAVAGE; MASTECTOMY; METASTASIS; MULTIPLE CYCLE TREATMENT; PLEURA EFFUSION; PRIORITY JOURNAL; THORACOCENTESIS; THORAX RADIOGRAPHY;

ANTIBODIES, MONOCLONAL; ANTINEOPLASTIC AGENTS; BREAST NEOPLASMS; FEMALE; HUMANS; LUNG DISEASES, INTERSTITIAL; MIDDLE AGED;

EID: 58549118448     PISSN: 01676806     EISSN: 15737217     Source Type: Journal    
DOI: 10.1007/s10549-008-9966-8     Document Type: Article

References (11)

1. E Romond A Perez 2005 Trastuzumab plus adjuvant chemotherapy for operable HER2-positive breast cancer N Engl J Med 353 1673 1684
2. M Piccart M Procter 2005 Trastuzumab after adjuvant chemotherapy in HER2-positive breast cancer N Engl J Med 353 1659 1672
3. D Slamon B Leyland 2001 Use of chemotherapy plus a monoclonal antibody against HER2 for metastatic breast cancer that overexpresses HER2 N Engl J Med 344 783 792
4. M Marty F Cogenitti 2005 Randomized phase II trial of the efficacy and safety of trastuzumab combined with docetaxel in patients with human epidermal growth factor receptor 2-positive metastatic breast cancer administered as first-line treatment: the M77001 study group J Clin Oncol 23 4265 4274
5. J Baselga X Carbonell 2005 Phase II study of efficacy, safety and pharmacokinetics of trastuzumab monotherapy administered on a 3-weekly schedule J Clin Oncol 23 2162 2171
6. N Cook-Burns 2001 Retrospective analysis of the safety of Herceptin immunotherapy in metastatic breast cancer Oncology 61 Suppl 2 58 66
7. B Vahid A Mehrotra 2006 Trastuzumab (Herceptin)-associated lung injury Respirology 11 655 658
8. E Radzikowska E Szczepulska 2003 Organising pneumonia caused by trastuzumab (Herceptin) therapy for breast cancer Eur Respir J 21 552 555
9. I Dimopoulou A Bamias 2006 Pulmonary toxicity from novel antineoplastic agents Ann Oncol 17 372 379
10. P Camus A Fanton 2004 Interstitial lung disease induced by drugs and radiation Respiration 71 301 326
11. PH Camus P Foucher 2001 Drug-induced infiltrative lung disease Eur Respir J 18 Suppl 32 93s 100s